Learn About Mevalonate Kinase Deficiency

What is the definition of Mevalonate Kinase Deficiency?

Mevalonate kinase deficiency is a condition characterized by recurrent episodes of fever, which typically begin during infancy. Each episode of fever lasts about 3 to 6 days, and the frequency of the episodes varies among affected individuals. In childhood the fevers seem to be more frequent, occurring as often as 25 times a year, but as the individual gets older the episodes occur less often.

Save information for later
Sign Up
What are the causes of Mevalonate Kinase Deficiency?

Mutations in the MVK gene cause mevalonate kinase deficiency. The MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme is involved in the production of cholesterol, which is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

How prevalent is Mevalonate Kinase Deficiency?

More than 200 people with mevalonate kinase deficiency have been reported worldwide; the majority of these individuals have HIDS.

Is Mevalonate Kinase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Mevalonate Kinase Deficiency Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Mevalonate Kinase Deficiency Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: October 01, 2018Published By: National Institutes of Health

What are the Latest Advances for Mevalonate Kinase Deficiency?
The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency.
Summary: The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency.
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
Summary: Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.
Tired of the same old research?
Check Latest Advances
What is confirmed in the treatment of autoinflammatory fever diseases?
Summary: What is confirmed in the treatment of autoinflammatory fever diseases?